Research ExplorerScientific StaffEray Gökkurt

Dr.med. ID: 5921880

Eray Gökkurt

graph of relations
Affiliations

Publications

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma

Research output: SCORING: Contribution to journal › Case report › Research › peer-review

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (23)